All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ABS-1230Phase 21 trial

    Actio Biosciences, Inc. · KCNT1-Related Epilepsy

  • ABSK141Phase 21 trial

    Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult

  • ABT-101DBPR112Phase 21 trial

    Anbogen Therapeutics, Inc. · Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations

  • AC102Phase 21 trial

    AudioCure Pharma GmbH · Hearing Loss, Sensorineural

  • AC591Phase 21 trial

    Shandong New Time Pharmaceutical Co., LTD · Colorectal Adenoma

  • ACCG-2671Phase 21 trial

    Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics · Obesity

  • ACDN-01Phase 21 trial

    Ascidian Therapeutics, Inc · Stargardt Disease, Cone Rod Dystrophy, Juvenile Macular Degeneration

  • ACE-86225106Phase 21 trial

    Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation

  • ACE1831Phase 21 trial

    Acepodia Biotech, Inc. · IgG4 Related Disease

  • AcmopatideCT-868, RO7795074Phase 21 trial

    Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus

  • ACP-211Phase 21 trial

    ACADIA Pharmaceuticals Inc. · Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant

  • ACR-2316Phase 21 trial

    Acrivon Therapeutics · Specific Advanced Solid Tumors

  • ACR-368prexasertibPhase 21 trial

    Acrivon Therapeutics · Endometrial Adenocarcinoma

  • ACT-777991Phase 21 trial

    Idorsia Pharmaceuticals Ltd. · Non-Segmental Vitiligo

  • ACT001Phase 21 trial

    Accendatech USA Inc. · Recurrent Glioblastoma Multiforme(GBM)

  • AD-211-HPhase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-211-LPhase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-211-MPhase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-2113Phase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-3031Phase 21 trial

    Moogene Medi Co., Ltd · Androgenetic Alopecia

  • AD-303APhase 21 trial

    Moogene Medi Co., Ltd · Androgenetic Alopecia

  • AD1208Phase 21 trial

    Avelos Therapeutics Inc. · Solid Tumor, Adult, Tumor, Solid, Solid Tumor

  • AdAPT-001Phase 21 trial

    EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms

  • adebeliizumabPhase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer

  • Beacon Therapeutics · X-Linked Retinitis Pigmentosa (XLRP)

  • ADI-212Phase 21 trial

    Adicet Therapeutics · Prostate Cancer Metastatic

  • ADX-097Phase 21 trial

    Akebia Therapeutics · IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy

  • ADX-629Phase 21 trial

    Aldeyra Therapeutics, Inc. · Alcohol Hepatitis

  • AFNT-211Phase 21 trial

    Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer

  • AFX3772Phase 21 trial

    GSK · Pneumonia, Bacterial, Pneumococcal Infections, Pneumonia, Pneumococcal

  • AG-120Phase 21 trial

    Bristol Myers Squibb · Leukemia, Myeloid, Acute

  • AG-221Phase 21 trial

    Bristol Myers Squibb · Leukemia, Myeloid, Acute

  • AGA2118Phase 21 trial

    Angitia Biopharmaceuticals · Postmenopausal Osteoporosis

  • AGLE-102Phase 21 trial

    Aegle Therapeutics · Dystrophic Epidermolysis Bullosa

  • AGMB-447Phase 21 trial

    Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)

  • AGN-193408Phase 21 trial

    AbbVie · Open-angle Glaucoma, Ocular Hypertension

  • AGP100Phase 21 trial

    Agiana Pharmaceuticals · Catecholaminergic Polymorphic Ventricular Tachycardia

  • AGS 22M6EAGS-22CEPhase 21 trial

    Merck & Co. · Bladder Cancer

  • AHB-171Phase 21 trial

    Ausper Biopharma Co., Ltd. · Hepatitis B, Chronic (CHB)

  • AI-081Phase 21 trial

    OncoC4, Inc. · Advanced Solid Tumor

  • AIC263029Phase 21 trial

    AiCuris Anti-infective Cures AG · BK Virus Infection, BKV Infection, Kidney Transplant

  • AION-301Phase 21 trial

    AION Healthspan, Inc. · Chronic Kidney Disease Stage 3

  • AIV007Phase 21 trial

    AiViva BioPharma, Inc. · Neovascular (Wet) Age-Related Macular Degeneration

  • ALC-2203-1Phase 21 trial

    Korea Arlico Pharm. Co., Ltd · Acute Bronchitis

  • ALC-2203-2Phase 21 trial

    Korea Arlico Pharm. Co., Ltd · Acute Bronchitis

  • ALC-2203-ACPhase 21 trial

    Korea Arlico Pharm. Co., Ltd · Acute Bronchitis

  • ALD-102Phase 21 trial

    Aldena Therapeutics · Alopecia Areata (AA)

  • Aldoxorubicin HClPhase 21 trial

    ImmunityBio, Inc. · Pancreatic Cancer

  • ALDP001Phase 21 trial

    Alixer Nexgen Therapeutics Limited · Seasonal Allergic Rhinitis (SAR)

  • ALG-000184Phase 21 trial

    Aligos Therapeutics · Chronic Hepatitis B Infection

NewerPage 42 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.